Evidence of a cross-protective immune response to influenza A in the cotton rat model

被引:31
作者
Straight, Timothy M.
Ottolini, Martin G.
Prince, Gregory A.
Eichelberger, Maryna C.
机构
[1] Brooke Army Med Ctr, Dept Clin Investigat, Ft Sam Houston, TX 78234 USA
[2] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA
[3] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA
[4] Virion Syst Inc, Rockville, MD 20850 USA
关键词
influenza; cotton rat; heterosubtypic immunity;
D O I
10.1016/j.vaccine.2006.05.092
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epidemiologic evidence suggests that cross-protective immune responses to influenza A viruses that have different hemagglutinin and neuraminidase subtypes occur in humans. This study characterized this heterosubtypic immunity in cotton rats (Sigmodon hispidus). Animals were infected with influenza A/PR/8/34 (H1N1)or A/Wuhan/359/95 (H3N2), and then challenged with A/Wuhan/359/95(H3N2) virus 4 weeks later. Viral titers, respiratory rates, and pathology of the respiratory tract following primary and secondary infection were compared. Cross-protection from heterosubtypic influenza A challenge in cotton rats was characterized by enhanced viral clearance, protection from tachypnea, a vigorous early cellular recall response, and a reduction in bronchiolar epithelial cell damage. Cross-protection was retained in steroid treated animals, in which the inflammatory recall response was minimal. Identification of the mechanisms that contribute to cross-protection in cotton rats may lead to the development of influenza vaccine strategies that are broadly protective. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6264 / 6271
页数:8
相关论文
共 24 条
[1]   Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or γδ T cells [J].
Benton, KA ;
Misplon, JA ;
Lo, CY ;
Brutkiewicz, RR ;
Prasad, SA ;
Epstein, SL .
JOURNAL OF IMMUNOLOGY, 2001, 166 (12) :7437-7445
[2]   Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor [J].
Eichelberger, MC ;
Prince, GA ;
Ottolini, MG .
VIROLOGY, 2004, 322 (02) :300-307
[3]   Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: An experiment of nature [J].
Epstein, SL .
JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (01) :49-53
[4]  
Epstein SL, 1997, J IMMUNOL, V158, P1222
[5]  
EPSTEIN SL, 2003, EXPERT REV ANTIINFEC, V1, P89
[6]   Modified M2 proteins produce heterotypic immunity against influenza A virus [J].
Frace, AM ;
Klimov, AI ;
Rowe, T ;
Black, RA ;
Katz, JM .
VACCINE, 1999, 17 (18) :2237-2244
[7]   Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus [J].
Heinen, PP ;
Rijsewijk, FA ;
de Boer-Luijtze, EA ;
Bianchi, ATJ .
JOURNAL OF GENERAL VIROLOGY, 2002, 83 :1851-1859
[8]   Exploring cross-protection between influenza strains by an epidemiological model [J].
Lavenu, A ;
Valleron, AJ ;
Carrat, F .
VIRUS RESEARCH, 2004, 103 (1-2) :101-105
[9]  
LIANG SH, 1994, J IMMUNOL, V152, P1653
[10]   A universal influenza A vaccine based on the extracellular domain of the M2 protein [J].
Neirynck, S ;
Deroo, T ;
Saelens, X ;
Vanlandschoot, P ;
Jou, WM ;
Fiers, W .
NATURE MEDICINE, 1999, 5 (10) :1157-1163